Cart
sales@molnova.com
ciscis-Muconic acid
CAS No. 1119-72-8
ciscis-Muconic acid( ciscis-Muconate | ciscis-24-Hexadienedioic acid )
Catalog No. M20235 CAS No. 1119-72-8
ciscis-Muconic acid is a naturally-occurring organic acid. It is used in the manufacture of several widely-used consumer plastics. Its microbial production via extending the shikimate pathway has been reported.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 43 | In Stock |
|
| 1G | 60 | In Stock |
|
Biological Information
-
Product Nameciscis-Muconic acid
-
NoteResearch use only, not for human use.
-
Brief Descriptionciscis-Muconic acid is a naturally-occurring organic acid. It is used in the manufacture of several widely-used consumer plastics. Its microbial production via extending the shikimate pathway has been reported.
-
Descriptionciscis-Muconic acid is a naturally-occurring organic acid. It is used in the manufacture of several widely-used consumer plastics. Its microbial production via extending the shikimate pathway has been reported.
-
In Vitro——
-
In Vivo——
-
Synonymsciscis-Muconate | ciscis-24-Hexadienedioic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1119-72-8
-
Formula Weight142.11
-
Molecular FormulaC6H6O4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL (140.74 mM)
-
SMILESOC(=O)\C=C\C=C/C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Sirpiglenastat
Sirpiglenastat (DRP-104), a glutamine antagonist and prodrug of DON, exhibits antitumor activity by inhibiting glutamine metabolism and stimulating both the innate and adaptive immune systems.
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
-
Bragsin2
Bragsin2 is a hydration-resistant cell penetrant, selective and non-competitive inhibitor of Afr guanine nucleotide exchange factor BRAG2.
